Home > Insider Trading > Filing (0001127602-14-012527)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
884731	Ariad Pharmaceuticals Inc	ARIA	Biological Products, (No Disgnostic Substances) (2836)	223106987

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1542768	E Maria Cantor	C/O Ariad Pharmaceuticals, Inc. 26 Landsdowne Street Cambridge MA 02139	Svp, Corporate Affairs And Hr	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-03-19	6,500	$0.00	80,774	No	4	M	Direct
Common Stock	Disposition	2014-03-19	2,061	$8.19	78,713	No	4	F	Direct
Common Stock	Acquisiton	2014-03-20	7,333	$0.00	86,046	No	4	M	Direct
Common Stock	Disposition	2014-03-21	3,667	$7.89	82,379	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2014-03-19	6,500	$0.00	6,500	$0.00
Common Stock	Restricted Stock Units	Disposition	2014-03-20	7,333	$0.00	7,333	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
13,000		2019-03-19	No	4	M	Direct
7,333		2022-03-20	No	4	M	Direct

Footnotes

Shares were acquired upon vesting of restricted stock units awarded on March 19, 2013.
Represents shares withheld to satisfy withholding tax requirements.
Shares were acquired upon vesting of restricted stock units awarded on March 20, 2012.
Represents shares sold to satisfy withholding tax requirements, pursuant to a Rule 10b5-1 trading plan.
Each restricted stock unit represents a right to receive one share of ARIAD common stock.
The restricted stock units vested on March 19, 2014.
The restricted stock units vested on March 20, 2014.